Operating Lease, Right-of-Use Asset of HERON THERAPEUTICS, INC. /DE/ from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $0 -$2,787,000 -100% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $708,000 -$2,761,000 -80% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,401,000 -$2,737,000 -66% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,091,000 -$2,703,000 -56% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $2,787,000 -$2,651,000 -49% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $3,469,000 -$2,600,000 -43% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $4,138,000 -$2,350,000 -36% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $4,794,000 -$2,277,000 -32% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $5,438,000 -$2,207,000 -29% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $6,069,000 -$2,135,000 -26% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $6,488,000 -$2,266,000 -26% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $7,071,000 -$2,224,000 -24% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $7,645,000 -$2,184,000 -22% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $8,204,000 -$5,998,000 -42% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $8,754,000 -$6,149,000 -41% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $9,295,000 -$6,299,000 -40% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $9,829,000 -$6,448,000 -40% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $14,202,000 -$2,739,000 -16% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $14,903,000 -$2,691,000 -15% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $15,594,000 -$2,645,000 -15% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $16,277,000 +$2,523,000 +18% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $16,941,000 +$4,695,000 +38% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $17,594,000 +$4,927,000 +39% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $18,239,000 +$5,171,000 +40% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $13,754,000 +$54,000 +0.39% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $12,246,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $12,667,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $13,068,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $13,700,000 01 Jan 2019 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.